Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Quadrise Fuels International (8QF) AI Stock Analysis

DE:8QF

Quadrise Fuels International

(Frankfurt:8QF)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Low financial leverageVery low leverage gives Quadrise greater financial flexibility while it develops its commercial pipeline. Limited debt reduces interest pressure and refinancing exposure, allowing more of its available resources to support trials, engineering work, and market expansion before revenues scale.
Negative Factors
Persistent unprofitable operationsThe current revenue base is not yet sufficient to cover Quadrise’s operating cost structure, leaving profitability structurally weak. Continued losses indicate that commercialization has not produced meaningful operating leverage, and the company remains dependent on future scale or external funding.

Quadrise Fuels International (8QF) vs. iShares MSCI Germany ETF (EWG)

-75%-50%-25%0%25%50%75%DE:8QF-60.00%EWG+4.43%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
EUR 31.41M
Dividend Yield
―
Average Volume (3M)
78.80K
Price to Earnings (P/E)
-6.9
Beta (1Y)
1.29
Revenue Growth
105.38%
EPS Growth
-20.00%
Country
Germany
Employees
10
Sector
Energy
Sector Strength
65
Industry
Oil & Gas Integrated

Quadrise Fuels International Business Overview & Revenue Model

Company Description

Quadrise Plc, an enterprise based in London, United Kingdom, and its associated companies, focus on the creation, promotion, and sale of distinctive emulsion-based fuels. These specialized fuels are primarily applied within the UK across diverse area...

Quadrise Fuels International Earnings Call Summary

Earnings Call Date:Mar 22, 2026(Q2-2026)|Next Earnings Date:Mar 28, 2027
Earnings Call SentimentPositive

The call conveys cautious optimism: multiple near-term operational positives (MSC/Cargill trial close, OCP traction, Valkor payments and pilot plan, USD 4.0M cash + expected receipts, strengthened team and R&D collaborations) signal momentum toward commercialization. However, material execution risks remain—legal/commercial finalization for the MSC trilateral agreement, Valkor pilot/sample delays, feedstock scaling complexity, regulatory/IMO timing uncertainty, and increased cash burn. Management presents these as manageable pragmatic issues rather than fundamental technology failures, resulting in a constructive but cautious outlook.

Positive Updates

Near-Term Progress on MSC / Cargill Trial
Management reports the MSC–Cargill–Quadrise trilateral trial agreement is close to signature; VAT concern for Antwerp resolved and a Belgian branch filed to avoid delays. Team describes remaining issues as pragmatic/legal rather than principal, and expects a single signing for the related agreements.

Negative Updates

Delays & Legal/Commercial Friction on MSC Signing
Agreement signature has been delayed by detailed commercial/legal negotiations (including tripartite wording and standard buyer terms). Management declined to give a hard timetable and notes large buyers’ internal priorities (e.g., fuel availability, geopolitical events) can slow decisions.

Company Guidance

The call set out clear near‑term milestones and cash guidance: cash at 31 Dec was $4.0m, historical cash burn ~$3.0m/yr (recently +10–15% → ~ $3.3–3.45m/yr), and management expects ~USD 950k–1.0m from Valkor (a $300k installment due end of month and ~$650k due end of year), plus small grant receipts (c.$12k recognized in the period; ~ $50k total grant cash); tax losses stand at ~£68m. Operational metrics and timing include two MSC/Cargill trials (MSAR and bioMSAR) now close to signature, an OCP trial of ~15–30 days depending on kiln size, Valkor pilot runs producing samples with pilot plant installation targeted in Q3 and full plant operational in Q4 and Quadrise’s unit shipping in Q2. Scale‑up planning covers a gross shortlist of ~25 refineries, an Antwerp branch filed, priority bunkering hubs (Singapore, N. Europe, Med, Americas), ISCC audit post‑commissioning, and technology constraints (MSAR ~30% water vs bioMSAR ~10% water); the company is also in an EU digital‑twin project with ~18 partners (modelling 4 existing + 4 new‑build vessel types) and has added hires (Matthew Hyde, 30+ years; Michael Covington), with 45 investor questions logged.

Quadrise Fuels International Peers Comparison

Overall Rating

UnderperformOutperform
Sector (65)

Financial Indicators

DE:8QF against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
GB:CASPGB:CASP74OutperformGBP 44.77M3.4422.39%―――
GB:NWFGB:NWF74OutperformGBP 79.85M8.7410.04%5.40%1.90%48.28%
GB:SEAGB:SEA66NeutralGBP 76.38M-32.88-18.42%――68.98%
Sector *65Neutral$15.17B7.614.09%5.20%3.87%-62.32%
GB:TLWGB:TLW48NeutralGBP 158.17M-3.9520.15%―-21.40%30.63%
GB:AETGB:AET45NeutralGBP 191.72M-20.60-9.14%―-6.06%-127.98%

* Energy Sector Average

Performance Comparison

-50%0%50%100%150%DE:8QFGB:CASPGB:NWFGB:AETGB:TLWGB:SEADec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
DE:8QF and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:8QFQuadrise Fuels International0.01-0.03-75.00%
GB:CASPCaspian Sunrise1.90-0.25-11.63%
GB:NWFNWF Group plc161.00-3.96-2.40%
GB:AETAfentra Plc70.8022.8047.50%
GB:TLWTullow Oil10.440.676.86%
GB:SEALongboat Energy Plc108.5040.1058.63%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.